Press Releases

October 08, 2018
Newly Published Data in Nature Medicine Show Potential of mRNA to Produce Therapeutic and Protective Protein Levels in Pre-Clinical Models of Acute Intermittent Porphyria
September 05, 2018
Dr. Wellington Sun Joins Moderna as Head, Vaccine Strategy and Regulatory Affairs
July 17, 2018
Moderna Opens New Manufacturing Site in Norwood, MA
July 11, 2018
Moderna Provides Mid-Year Corporate Update
June 14, 2018
Former Akamai CEO Paul Sagan Joins Moderna’s Board of Directors
May 03, 2018
Moderna and Merck Expand mRNA Cancer Vaccines Collaboration
April 24, 2018
Lori Henderson Joins Moderna as General Counsel and Corporate Secretary
April 04, 2018
Megan Pace Joins Moderna as Chief Corporate Affairs Officer
February 20, 2018
Newly Published Data Highlight Moderna’s mRNA Platform in Advancing Prophylactic Vaccine for Cytomegalovirus (CMV) Infections
February 01, 2018
Moderna Closes $500 Million Equity Financing

Media Coverage

Chemical & Engineering News
May 03, 2018

Merck partners with Moderna to test KRas cancer vaccines in humans

December 19, 2017

Can a multibillion-dollar biotech prove its RNA drugs are safe for a rare disease?

November 15, 2017

This $5 Billion Startup Made Its First Cancer Vaccine—For Just One Person

September 14, 2017

Moderna initiates Chikungunya vaccine human test, replaces backup Zika candidate

Reuters News
September 14, 2017

Moderna, AstraZeneca heart drug succeeds early-stage trial

Endpoints News
September 14, 2017

AstraZeneca and Moderna take a big, early step forward in their quest to prove mRNA works in humans

Endpoints News
August 03, 2017

Top Novartis manufacturing exec jumps ship, takes charge of industrializing Moderna’s mRNA tech

August 03, 2017

Moderna brings on former Novartis exec to oversee manufacturing of mRNA therapies

Boston Business Journal
August 03, 2017

Moderna taps Novartis exec to lead manufacturing blitz
June 07, 2017

‘Don’t underestimate Merck’s vaccine business,’ says CEO